Drilldown: Medicines

None · Codeine · 1,4-Butanediol · 1B-LSD · 1cP-LSD · 1P-LSD · 1V-LSD · 2-AI · 2-FA · 2-FDCK · 2-FMA · 25B-NBOH · 25B-NBOMe · 25C-NBOH · 25C-NBOMe · 25I-NBOH · 25I-NBOMe · 25N-NBOMe · 2C-B · 2C-B-FLY

Other values:

Search

None (2) · Desyrel (original IR), Oleptro (ER), Trittico (1)

Classic Psychedelic (2) · Lysergamide (1) · Phenethylamine (1) · Research material (2) · [[:Category:Antidepressants|Antidepressant]] (1) · [[:Category:SARIs|Serotonin antagonist and reuptake inhibitor (SARI)]] (1) · [[:Category:Sleep aids|Sleep aid]] (1)

Extremely potent 5-HT2A agonist; vasoconstrictor (1) · Prodrug of LSD; 5-HT2A agonist (1) · '"`UNIQ--vote-00000017-QINU`"' '''Priapism''' is a recognized rare adverse effect via α1 antagonism in penile vasculature and is the marquee counseling point for male patients'"`UNIQ--ref-00000018-QINU`"'. (1)

None (2) · '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"', '"`UNIQ--vote-0000001B-QINU`"', '"`UNIQ--vote-0000001C-QINU`"' (1)

None (2) · Insomnia (off-label): 25-50 mg PO at bedtime, titrate to effect. Depression: 150 mg/day divided BID-TID; titrate to 400 mg/day outpatient or 600 mg/day inpatient (1)

None (2) · IR tablets 50, 100, 150, 300 mg; Oleptro ER tablets 150, 300 mg (1)

None (2) · 400 mg/day outpatient; 600 mg/day inpatient (1)

None (2) · Oral (1)

None (2) · Sleep effect within 30-60 minutes; antidepressant effect over 1-2 weeks (1)

None (2) · ~6-8 hours (IR); 24 hours (Oleptro ER) (1)

None (2) · Biphasic: ~3-6 hours alpha, ~5-9 hours beta'"`UNIQ--ref-0000001D-QINU`"' (1)

None (2) · ~65% (oral)'"`UNIQ--ref-0000001E-QINU`"' (1)

None (2) · Limited human data; observational signals inconclusive.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)

None (2) · [[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-0000001F-QINU`"' (1)